Campbell; Jeffrey Allen
Patent Applications and Registrations
Patent applications and USPTO patent grants for Campbell; Jeffrey Allen.The latest application filed is for "hepatitis c virus inhibitors".
Company Profile
0.29.26
- Campbell; Jeffrey Allen - Hilton Head Island SC US
- Campbell; Jeffrey Allen - Cheshire CT
- Campbell; Jeffrey Allen - Bethlehem PA
- Campbell; Jeffrey Allen - Glen Gardner NJ
- Campbell; Jeffrey Allen - Fremont CA
- Campbell, Jeffrey Allen - Middletown CT
Patent Activity
| Patent | Date |
|---|---|
| Methods for treating cancer and non-neoplastic conditions Grant 9,351,964 - Almstead , et al. May 31, 2 | 2016-05-31 |
| Hepatitis C Virus Inhibitors App 20120330019 - Wang; Xiangdong Alan ; et al. | 2012-12-27 |
| Methods For Treating Hepatitis C App 20120009142 - Karp; Gary Mitchell ; et al. | 2012-01-12 |
| Methods For Treating Hepatitis C App 20110268698 - KARP; Gary M. ; et al. | 2011-11-03 |
| Methods for treating hepatitis C Grant 8,013,006 - Karp , et al. September 6, 2 | 2011-09-06 |
| Methods for treating hepatitis C Grant 7,973,069 - Karp , et al. July 5, 2 | 2011-07-05 |
| Methods for treating hepatitis C Grant 7,868,037 - Karp , et al. January 11, 2 | 2011-01-11 |
| Methods For Treating Hepatitis C App 20100305100 - Karp; Gary Mitchell ; et al. | 2010-12-02 |
| Methods for treating hepatitis C Grant 7,781,478 - Karp , et al. August 24, 2 | 2010-08-24 |
| Methods for treating hepatitis C Grant 7,772,271 - Karp , et al. August 10, 2 | 2010-08-10 |
| Hepatitis C virus inhibitors Grant 7,741,281 - D'Andrea , et al. June 22, 2 | 2010-06-22 |
| Hepatitis C virus inhibitors Grant 7,449,479 - Wang , et al. November 11, 2 | 2008-11-11 |
| Indole derivatives as anti-inflammatory agents Grant 7,410,994 - Broka , et al. August 12, 2 | 2008-08-12 |
| Methods for treating Hepatitis C App 20080096928 - Karp; Gary Mitchell ; et al. | 2008-04-24 |
| Hepatitis C virus inhibitors Grant 7,309,708 - Tu , et al. December 18, 2 | 2007-12-18 |
| Hepatitis C virus inhibitors App 20070099825 - D'Andrea; Stanley ; et al. | 2007-05-03 |
| Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus Grant 7,173,004 - McPhee , et al. February 6, 2 | 2007-02-06 |
| Hepatitis C virus inhibitors Grant 7,135,462 - Scola , et al. November 14, 2 | 2006-11-14 |
| Hepatitis C virus inhibitors Grant 7,132,504 - Scola , et al. November 7, 2 | 2006-11-07 |
| Methods for treating Hepatitis C App 20060223863 - Karp; Gary Mitchell ; et al. | 2006-10-05 |
| Methods for treating hepatitis C App 20060189606 - Karp; Gary Mitchell ; et al. | 2006-08-24 |
| Indole derivatives as anti-inflammatory agents App 20060178420 - Broka; Chris Allen ; et al. | 2006-08-10 |
| Hepatitis C virus inhibitors App 20060172950 - Wang; Xiangdong Alan ; et al. | 2006-08-03 |
| Indole derivatives as anti-inflammatory agents Grant 7,074,939 - Broka , et al. July 11, 2 | 2006-07-11 |
| Hepatitis C virus inhibitors Grant 7,041,698 - Ripka , et al. May 9, 2 | 2006-05-09 |
| Hepatitis C virus inhibitors Grant 6,995,174 - Wang , et al. February 7, 2 | 2006-02-07 |
| Hepatitis C virus inhibitors App 20050267040 - Scola, Paul Michael ; et al. | 2005-12-01 |
| Hepatitis C virus inhibitors App 20050187165 - Scola, Paul Michael ; et al. | 2005-08-25 |
| Indole derivatives as anti-inflammatory agents App 20050176803 - Broka, Chris Allen ; et al. | 2005-08-11 |
| Hepatitis C virus inhibitors App 20050143316 - Tu, Yong ; et al. | 2005-06-30 |
| Macrocyclic isoquinoline peptide inhibitors of Hepatitis C virus App 20050090432 - McPhee, Fiona ; et al. | 2005-04-28 |
| Substituted cycloalkyl P1' hepatitis C virus inhibitors Grant 6,878,722 - Campbell , et al. April 12, 2 | 2005-04-12 |
| Indole derivatives as anti-inflammatory agents Grant 6,872,744 - Broka , et al. March 29, 2 | 2005-03-29 |
| Hepatitis C virus inhibitors Grant 6,872,805 - Campbell , et al. March 29, 2 | 2005-03-29 |
| Heterocyclicsulfonamide hepatitis C virus inhibitors Grant 6,869,964 - Campbell , et al. March 22, 2 | 2005-03-22 |
| Inhibitors of hepatitis C virus Grant 6,867,185 - Campbell , et al. March 15, 2 | 2005-03-15 |
| Sulfonamide hydroxamates Grant 6,844,366 - Billledeau , et al. January 18, 2 | 2005-01-18 |
| Sulfonamide compounds Grant 6,787,559 - Billledeau , et al. September 7, 2 | 2004-09-07 |
| Hepatitis C virus inhibitors App 20040106559 - Wang, Xiangdong Alan ; et al. | 2004-06-03 |
| Substituted cycloalkyl P1' hepatitis C virus inhibitors App 20040077551 - Campbell, Jeffrey Allen ; et al. | 2004-04-22 |
| Heterocyclicsulfonamide hepatitis C virus inhibitors App 20040072761 - Campbell, Jeffrey Allen ; et al. | 2004-04-15 |
| Hepatitis C virus inhibitors App 20040048802 - Ripka, Amy ; et al. | 2004-03-11 |
| Inhibitors of hepatitis C virus App 20040038872 - Campbell, Jeffrey Allen ; et al. | 2004-02-26 |
| Sulfonamide compounds App 20030216405 - Billledeau, Roland Joseph ; et al. | 2003-11-20 |
| Sulfonamide hydroxamates App 20030199520 - Billledeau, Roland Joseph ; et al. | 2003-10-23 |
| Indole derivatives as anti-inflammatory agents App 20030130337 - Broka, Chris Allen ; et al. | 2003-07-10 |
| Processes for preparing 3-arylsulfur hydroxamic acids App 20020133030 - Campbell, Jeffrey Allen ; et al. | 2002-09-19 |
| Hepatitis C virus inhibitors App 20020111313 - Campbell, Jeffrey Allen ; et al. | 2002-08-15 |
| Sulfamide-metalloprotease inhibitors Grant 6,376,506 - Broka , et al. April 23, 2 | 2002-04-23 |
| Processes for preparing 3-arylsulfur hydroxamic acids App 20020038037 - Campbell, Jeffrey Allen ; et al. | 2002-03-28 |
| Sulfamide-metalloprotease inhibitors Grant 6,143,744 - Broka , et al. November 7, 2 | 2000-11-07 |
| Sulfamide-metalloprotease inhibitors Grant 6,130,220 - Broka , et al. October 10, 2 | 2000-10-10 |
| Sulfamide-metalloprotease inhibitors Grant 5,998,412 - Broka , et al. December 7, 1 | 1999-12-07 |
| Matrix metalloprotease inhibitors Grant 5,932,595 - Bender , et al. August 3, 1 | 1999-08-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 